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DObjective: As outcomes for the Fontan procedure have improved, it has become more difficult to select between
a single-ventricle repair or biventricular repair for patients with complex anatomy and 2 ventricles. However, late
complications after the Fontan procedure remain a concern. Our strategy, which has favored an aggressive pref-
erential approach for biventricular repair in these patients, has also been applied to patients initially treated on
a single-ventricle track elsewhere.
Methods: Nine patients (4 male patients) who had previously undergone the Fontan procedure (n ¼ 3) or bidi-
rectional cavopulmonary shunting (n ¼ 6) with intent for a later Fontan procedure were referred to our center for
complex 11/2- or 2-ventricle repair over the last 10 years. Indications for conversion in these patients were protein-
losing enteropathy (n ¼ 2), pulmonary arteriovenous malformation (n ¼ 1), and preference for biventricular
anatomy (n ¼ 6). The conversion mainly consisted of takedown of the Fontan procedure or bidirectional cavo-
pulmonary shunt connection, reconstruction of 1 or both of venae cavae, creation of an intraventricular pathway
for left ventricular output, and placement of a right ventricle–pulmonary artery conduit (Rastelli-type operation).
Results: Five patients underwent 11/2-ventricle repair, and 4 had complete biventricular repair. Median cardiopul-
monary bypass and aortic crossclamp times were 202 minutes (range, 169–352 minutes) and 129 minutes (range,
100–168 minutes), respectively. There were 2 early deaths and 1 late death. At a median follow-up of 27 months
(range, 3.3–99.8 months), all survivors are in New York Heart Association class I.
Conclusions: Patients initially treated with intent to perform single-ventricle palliation can be converted to
11/2- or 2-ventricle physiology with acceptable outcomes. (J Thorac Cardiovasc Surg 2011;141:419-24)The Fontan procedure has undergone continual refinement
over the past 2 decades. Technical modifications have re-
sulted in excellent early and midterm results.1-3 These
outcomes have expanded the use of the Fontan procedures
not only for anatomically, functionally, or both single-
ventricle (SV) patients but also for those thought to have
untreatable complex intracardiac anatomy with 2 relatively
adequately sized ventricles.
Late complications of the Fontan circulation remain man-
agement challenges, such as protein-losing enteropathy
(PLE), pulmonary arteriovenous malformations (PAVMs),
plastic bronchitis, arrhythmia, thromboembolism, and ventric-
ular failure.4-7 In addition, the life expectancy and exercise
capacity of patients undergoing a Fontan procedure are also
of concern.8-11
Despite these concerns over the long-term outcomes of the
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The Journal of Thoracic and Cabe too risky to establish biventricular circulation, even in
the presence of 2 adequate ventricles.12-15 In particular, the
challenge of ventricular septation and intraventricular
rerouting might cause some surgeons to hesitate to pursue
a biventricular approach because of the technical difficulty,
the risk of surgical heart block, left ventricular outflow
tract obstruction (LVOTO) and iatrogenic atrioventricular
valve regurgitation, and the need for a right ventricle
(RV)–pulmonary artery (PA) conduit. These disadvantages
of complex biventricular repair (BVR) must be balanced
against the late complications of the Fontan procedure.
In an attempt to avoid late Fontan complications, an alter-
native procedure, 11/2-ventricle repair, was developed
16 for
patients with an insufficiently sized pulmonary ventricle.
The potential benefit of this operation is the achievement
of a physiological separation of the pulmonary and systemic
circulations with the maintenance of pulsatile blood flow in
the PAs by diverting the superior vena caval blood to return
directly into the PAs through a bidirectional cavopulmonary
shunt (BCPS). This technique can result in normal periph-
eral oxygen saturation while reducing the volume load on
the pulmonary ventricle.17
In general, our strategy has favored an aggressive prefer-
ential approach to BVR. This approach has also been applied
to patients initially treated on an SV track elsewhere. This re-
port reviews our surgical experience with these challenging
patients.rdiovascular Surgery c Volume 141, Number 2 419
Abbreviations and Acronyms
BCPS ¼ bidirectional cavopulmonary shunt
BVR ¼ biventricular repair
CAVSD ¼ complete atrioventricular septal defect
DORV ¼ double-outlet right ventricle
ECC ¼ extracardiac conduit
LV ¼ left ventricle
LVOTO ¼ left ventricular outflow tract
obstruction
PA ¼ pulmonary artery
PAVM ¼ pulmonary arteriovenous
malformation
PLE ¼ protein-losing enteropathy
PS ¼ pulmonary stenosis
RV ¼ right ventricle
SV ¼ single ventricle
TGA ¼ transposition of the great arteries
VSD ¼ ventricular septal defect
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DMATERIALS AND METHODS
Patients
From 2000 to 2009, a total of 9 patients (4 male patients) who had pre-
viously undergone a Fontan procedure or BCPS with intent for a later Fon-
tan procedure were referred to C.S. Mott Children’s Hospital, University of
Michigan Health Systems, for further surgical treatment (Table 1). This
study was approved by the University of Michigan Medical School Institu-
tional Review Board for Human Subject Research.
The primary diagnosis was l-transposition of the great arteries (TGA)
with ventricular septal defect (VSD) and pulmonary atresia (n ¼ 3),
double-outlet right ventricle (DORV) with pulmonary stenosis (PS;
n¼ 3), d-TGAwith VSD and PS or pulmonary atresia (n¼ 2), and LVOTO
with VSD (n ¼ 1).
These patients underwent a variety of previous interventions, which are
summarized in Table 1. The patients had been deemed Fontan candidates
because of the existence of an inadequately sized ventricle (n ¼ 4), unsuit-
able atrial anatomy for atrial switch (n¼ 3), unsuitable VSD for creating in-
traventricular rerouting (n¼ 2), and limited anterior chest space for insertion
of an RV–PA conduit (n ¼ 1). All of the patients had undergone 2 or more
interventions. The last operation before presentation at our institution was
a BCPS with intent for a later Fontan procedure in 6 patients and a Fontan
procedure in 3 patients. Eight of the 9 patients had preoperative cardiac
catheterization data (Table 2).
Surgical Techniques
The operationwas performedwith standard bicaval cardiopulmonary by-
pass. The conversion involved the reconstruction of the systemic venous
system by means of takedown of the Fontan or BCPS connections and re-
construction of 1 or both of the venae cavae. Left and right ventricular egress
was provided by the creation of an intraventricular pathway from the VSD to
the aorta to provide left ventricular (LV) outflow and the placement of an
RV–PA conduit (Rastelli-type operation). The VSD was enlarged anterosu-
periorly in 4 patients at the discretion of the operating surgeon. The atrial
septal defect was completely closed in 6 patients, whereas 3 patients with
a hypoplastic RV underwent partial atrial septal defect closure with a 2.8-
mm fenestrated polytetrafluoroethylene patch. Delayed sternal closure
was applied in 5 patients.420 The Journal of Thoracic and Cardiovascular SurgSpecific techniques were applied according to individual anatomy. Three
patients with a relatively hypoplastic RV underwent RV enlargement by
means of division or resection of RV trabecular myocardium.18 For the 2
patients with bilateral BCPSs, the left superior venae cavae were anasto-
mosed end-to-side to the right superior venae cavae at the 11/2-ventricle re-
pair in an effort to minimize caval hypertension theoretically exacerbated by
means of pulsatile blood flow from an RV–PA conduit directly up the supe-
rior vena cava.
Patient 8 (DORV, pulmonary atresia, and complete atrioventricular sep-
tal defect [CAVSD]) required a unique reconstruction. She had previously
undergone an extracardiac conduit (ECC) Fontan procedure with bilateral
BCPS. For the systemic venous reconstruction, both PAs were transected
distal to the BCPS anastomoses, leaving the central portion of the PA to
serve as the neoinnominate vein. A short segment of the distal ECC was
then used as the superior vena cava to the right atrium. The inferior vena
cava was reattached to the right atrium with a short segment of the proximal
ECC. The DORV and CAVSDwere repaired with closure of the VSD to the
aorta. A bifurcated pulmonary allograft was used to create an RV to both
branch PAs continuity. The proximal end of allograft was anastomosed to
RV anterior wall. One of the distal end was anastomosed to the left PA
directly, then a 12-mm ringed expanded polytetrafluoroethylene graft was
interposed between the right PA and the other distal end of the allograft.RESULTS
Indications for conversion in these patients were PLE
(n ¼ 2), PAVMs (n ¼ 1), and preference for biventricular
anatomy (n¼ 6, Table 1). Patients 7 and 9, who had a Fontan
circulation, had persistent PLE. Patient 8, who had undergone
an ECC Fontan procedure after the Kawashima procedure,
also had extensive left-sided PAVMs and severe cyanosis.
Six patients underwent 11/2-ventricle repair (one of which
was the staging procedure for the later complete BVR), and 3
had a primary complete BVR (Table 3). In addition to the
Rastelli-type repairs, the concomitant procedures were atrial
switch for l-TGA in 3 patients, inferior vena caval recon-
struction for a takedown of Fontan connection in 2 patients,
superior vena caval reconstruction for complete BVR in 3
patients, and VSD enlargement in 4 patients. The median
cardiopulmonary bypass and aortic crossclamp times were
202 minutes (range, 169–352 minutes) and 129 minutes
(range, 100 –168 minutes), respectively.
There were 2 early deaths (Table 3). Patient 5 (l-TGA,
pulmonary atresia, and VSD) with moderate-to-severe mi-
tral regurgitation underwent 11/2-ventricle repair consisting
of a Senning procedure combined with Rastelli-type opera-
tion andmitral valvuloplasty. Her chest was able to be closed
4 days postoperatively. However, she had junctional ectopic
tachycardia with profound hypotension 2 days later and was
unable to be resuscitated. Patient 6 (d-TGA, PS, and single
coronary artery) had diminished function of both ventricles
before the operation. He underwent biventricular conversion
consisting of BCPS division, VSD enlargement, and a Ras-
telli-type operation. At weaning from CPB, his ventricular
function was severely decreased, and he required extracor-
poreal life support. An echocardiogram at that time showed
mild-to-moderate global LV dysfunction without segmental
wall motion abnormality and was otherwise unremarkable.ery c February 2011
TABLE 1. Summary of preoperative patients’ characteristics
Patient
no. Sex Diagnosis (factors believed to favor SV palliation) Previous interventions (age) Indication for conversion
1 F l-TGA, pulmonary atresia, VSD (left juxtaposed
atrial appendages)
BTS, PA augmentation (6 d)
Left PA unifocalization, central
shunt (6 mo)
BCPS (13 mo)
Preference for biventricular anatomy
2 M DORV, PS, VSD, hypoplastic arch (believed
to have too limited space for conduit insertion)
BTS, arch repair, modified DKS (12 d)
Balloon aortoplasty (9 mo)
BCPS (15 mo)
Preference for biventricular anatomy
3 F DORV, PS, VSD, dextrocardia (hypoplastic LV) BTS
BCPS (9 mo)
Preference for biventricular anatomy
4 F l-TGA, pulmonary atresia, VSD (situs
inversus, levocardia)
BTS
BCPS (6 mo)
Preference for biventricular anatomy
5 F l-TGA, pulmonary atresia, VSD (dextrocardia) BTS (8 d)
BCPS (15 mo)
Preference for biventricular anatomy
6 M d-TGA, PS BCPS (15 mo) Preference for biventricular
anatomy (restrictive VSD)
7 M d-TGA, pulmonary atresia (remote VSD,
hypoplastic RV)
Right BTS (1 d)
Left BTS (7 mo)
Bilateral BCPS, PA
augmentation (18 mo)
ECC (6 y)
Protein-losing enteropathy
8 F DORV, PS, CAVSD (hypoplastic RV,
left isomerism)
Kawashima, main PA ligation (6 mo)
Hepatic vein to PA connection
(ECC) (3.5 y)
Severe pulmonary arteriovenous
malformations
9 M LVOTO, VSD (hypoplastic RV) BTS, modified DKS (age?)
Fontan procedure (age?)
Protein-losing enteropathy
SV, Single ventricle; TGA, transposition of the great arteries; VSD, ventricular septal defect; BTS, Blalock–Taussig shunt; PA, pulmonary artery; BCPS, bidirectional cavopulmo-
nary shunt; DORV, double-outlet of right ventricle; PS, pulmonary stenosis; DKS, Damus–Kaye–Stansel anastomosis; LV, left ventricle; RV, right ventricle; ECC, extracardiac
conduit; CAVSD, complete atrioventricular septal defect; LVOTO, left ventricular outflow tract obstruction.
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cardiac catheterization was performed 2 days later to assess
the coronary anatomy, which detected a tight narrowing in
the proximal left anterior descending coronary artery. This
stenosis was repaired; however, ventricular function did
not recover.
Late Outcomes in Successfully Repaired Patients
Median follow-up was 27 months (range, 3.3–99.8
months). There was 1 late death 1.5 years after surgicalTABLE 2. Preoperative catheter examination
Patient
no. BSA (m2) LVESP (mm Hg) LVEDP (mm Hg) RVESP (m
1 0.49 98 8 9
2 0.59 86 10
3 0.70 130 8 12
4 0.47 95 12
5 Did not undergo pr
6 0.52 86 2 9
7 1.00 95 10 9
8 0.70 82 10
9 0.86 115 14 9
BSA, Body surface area; LVESP, left ventricular end-systolic pressure; LVEDP, left ventricul
ventricular end-diastolic pressure; PVR, pulmonary vascular resistance; CI, cardiac index.
The Journal of Thoracic and Caintervention caused by sepsis associated with unresolved
PLE. All survivors have normal peripheral oxygen satura-
tions. Quantitatively, RV function has remained normal in
all late survivors, and although LV function has deteriorated
in 1 patient, all patients remain in New York Heart Associ-
ation functional class I. Further interventions have been re-
quired in 3 patients: device closure of residual septal
defects in 1 patient, Senning pathway revision and RV–PA
conduit replacement in 1 patient, and RV–PA conduit
replacement, pacemaker implantation for sick sinusm Hg) RVEDP (mm Hg) Qp/Qs
PVR
(u $ m2) CI (L/min $ m2)
8 8 0.56 2.0 4.1
0.57 1.0 5
4 11 0.50 1.6 3.4
0.67
eoperative catheterization
0 4 0.86 1.3 8.9
0 6 1.00 5.1
1.00
4 10 0.80 3.2 3.1
ar end-diastolic pressure; RVESP, right ventricular end-systolic pressure; RVEDP, right
rdiovascular Surgery c Volume 141, Number 2 421
TABLE 3. Summary of patients undergoing 11/2- or 2-ventricle conversion
Patient
no.
Age
(y)
Weight
(kg) Conversion procedure Repair
CPB time
(min)
AXC time
(min)
Outcome
(cause of death)
1 2.4 11 Rastelli, Mustard 1.5 169 100 Alive
2 3.9 14 Rastelli 1.5 195 131 Alive
3 7.8 17 Rastelli, VSD enlargement, mVSD closure 1.5 200 110 Alive
4 2 12 Rastelli, Senning, rt BCPS division,
VSD enlargement
1.5 (/2) 202 129 Alive
5 5.7 23 Rastelli, Senning,
mitral valve repair
1.5 253 142 Early death
6 2.3 11 Rastelli, BCPS division, VSD enlargement 2 202 109 Early death
7 9.0 31 Rastelli, takedown Fontan, RV sinus myectomy 1.5 352 168 Alive, PLE improved
8 5.3 17 CAVSD repair, Rastelli, takedown Fontan,
RV sinus myectomy
2 302 145 Alive, PAVM resolved
9 7.4 26 Rastelli, takedown Fontan, VSD enlargement,
RV sinus myectomy
2 196 128 Late death, PLE not improved
CPB, Cardiopulmonary bypass; AXC, aortic crossclamp; VSD, ventricular septal defect; mVSD, muscular VSD; BCPS, bidirectional cavopulmonary shunt; RV, right ventricular;
PLE, protein-losing enteropathy; CAVSD, complete atrioventricular septal defect; PAVM, pulmonary arteriovenous malformation.
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Dsyndrome, and coil embolization of collateral vessels in 1
patient. Four patients have had follow-up cardiac catheteri-
zation (Table 4).
DISCUSSION
Our center has pursued a policy of BVR for the majority
of patients presenting at birth with 2 reasonably sized func-
tional ventricles, even in the presence of complex intraven-
tricular anatomy. It is our belief that BVR will result in
a better long-term functional outcome for these patients.
Ohuchi and colleagues19 compared the long-term cardiopul-
monary responses to exercise among 14 patients undergoing
the Fontan procedure and 13 patients undergoing BVR for
double-inlet left ventricle. They found that the BVR group
showed superior exercise capacity and suggested that this
finding would relate to a better long-term prognosis.
We have also applied this strategy to patients initially pal-
liated with intent to perform SV palliation at other institu-
tions. Results of the conversion of patients undergoing
SV palliation to 11/2- or 2-ventricle physiology are good.TABLE 4. Postoperative cardiac catheter examination of patients undergo
Patient
no. BSA (m2)
Interval
postoperative (mo)
LVESP
(mm Hg)
LVED
(mm H
1 0.60 7 115 8
2 No data (has not undergo
3 No data (has not undergo
4 6 95 8
5 No da
6 No da
7 No data (has not undergo
8 0.80 16 88 12
9 1.03 4 87 8
BSA, Body surface area; LVESP, left ventricular end-systolic pressure; LVEDP, left ventricu
tricular end-systolic pressure; RVEDP, right ventricular end-diastolic pressure; CI, cardiac
422 The Journal of Thoracic and Cardiovascular SurgHowever, as with all complex operations in challenging
patients, careful consideration of the risks and benefits
must be weighed. The candidates for biventricular conver-
sion can be divided into 2 categories. The first group is pa-
tients requiring BVR for significant complications of their
Fontan physiology or who are partway through their staged
palliation and deemed to be poor candidates for a Fontan
procedure. The second group is comprised of those that
are doing well with their Fontan procedure but are undergo-
ing conversion for the long-term benefits of normal biven-
tricular physiology.
All 3 of the patients with a completed Fontan circulation
were in the former group, with PLE (n ¼ 2) or PAVMs with
severe cyanosis (n ¼ 1). For these patients, the PAVMs re-
solved after biventricular conversion, and the PLE was im-
proved in 1 of 2 patients after 11/2-ventricle conversion.
Other options for late Fontan complications have been de-
scribed, such as revision of an atriopulmonary Fontan proce-
dure to an ECC.20,21 However, although these revisions are
often successful in resolving issues such as arrhythmia, theying 11/2- or 2-ventricle conversion
P
g)
mPAP
(mm Hg)
RVESP
(mm Hg)
RVEDP
(mm Hg) CI (L/min $ m2)
14 50 9 5.1
ne a postoperative catheterization)
ne a postoperative catheterization)
32 50 15
ta (early death)
ta (early death)
ne a postoperative catheterization)
14 49 8 4.3
15 35 9 3.7
lar end-diastolic pressure; mPAP, mean pulmonary artery pressure; RVESP, right ven-
index.
ery c February 2011
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Ddo not change the underlying SV physiology and might not
address complications such as PLE, which are thought to be
related to the Fontan circulation. In this study 2 patients
survived, whereas 1 ultimately succumbed to unresolved
PLE. Unfortunately, because even heart transplantation
does not always halt the progression of PLE, attempts at
BVR in this population with severe life-threatening compli-
cations of Fontan palliation would seem indicated.
The latter group, those patients on an SV pathwaywith sat-
isfactory hemodynamics presenting for conversion to BVR,
present amore difficult decision-making process.Of the 6 pa-
tients in this category, there were 2 early deaths. One must
weigh the potential long-term complications of the Fontan
procedure against the operative risk of BVR, the need for re-
operation, and the benefits of 11/2- or 2-ventricle physiology.
Determining whether there were preoperative characteris-
tics that differentiated survivors from nonsurvivors would be
important. However, objective morphological criteria, such
as ventricular volumes determined by means of cardiac cath-
eterization, were not recorded, and these subjects predated
our routine use of cardiacmagnetic resonance imaging.Other
objective data, such as routine catheterization hemodynam-
ics, were not different between groups, and the sample size
limits the ability to detect subtle differences. However,
with regard to the 2 early deaths, these patients differed
from the remaining 7 patients in that both had a preoperative
functional problem in the left heart; patient 5 had severe mi-
tral valve regurgitation, and patient 6 had diminished LV
function. Although not a statistically significant finding, it
might be that patients with preexisting left heart issues would
be better served by cardiac transplantation or continuing ex-
pectant management in the case of the asymptomatic patient.
Another concern are the long-term outcomes of the 4 pa-
tients with 11/2-ventricle physiology. Whereas 1
1/2-ventricle
repair has a more physiological circulation than the Fontan
procedure and might avoid late complications associated
with Fontan circulation, Numata and associates22 demon-
strated the long-term exercise capacity in patients with pul-
monary atresia with intact ventricular septum, which showed
that 11/2-ventricle physiology showed late exercise intoler-
ance, as seen in patients undergoing the classic Fontan pro-
cedure, and was inferior to the biventricular physiology.
Also, pulsatile flow in the superior vena cava can also lead
to complications.17 Kim and coworkers23 reviewed 114 pa-
tients who underwent 11/2-ventricle repair. Serious superior
vena cava–related complications occurred in 3 (2.6%) pa-
tients, and mild complications occurred in 5 (4.4%) patients.
A potential role for 11/2-ventricle repair is as an interstage
procedure before complete BVR. Fontan physiology results
in a lower ventricular reserve capacity, or potential compli-
ance under increased loading conditions, than normal biven-
tricular physiology primarily because of reduced systemic
ventricular preload.24 The sudden increase in ventricular
preload associated with primary complete biventricular con-The Journal of Thoracic and Caversionmight excessively stress the systemic ventricular, and
thus this staging approach might lead to improved results.
Several reasons were cited for not performing an initial
BVR in the patients in this report. Three patients had been
judged not to be candidates for BVR because of hypoplasia
of the RV. However, these patients were able to undergo RV
sinus myectomy associated with the conversion operation,
and their RV function has been preserved. We and other au-
thors consider that BVR, with or without a BCPS to reduce
RV volume load, is possible even if the RV is hypoplastic
but there is an adequate sized right-sided atrioventricular
valve.13
The other indications for SV palliation in this patient
group were l-TGA, CAVSD with DORV, DORV with re-
mote VSD, and heterotaxy syndrome with complex ventric-
ular and atrial anatomy. All these anomalies have in
common the need for complex intraventricular rerouting of
the LV output through the VSD to the semiluminar valve.
The complex intracardiac tunnels, which often require
VSD enlargement, place the patient at risk for surgical heart
block or LVOTO. In this series no patient had heart block,
and no long-term survivor has required a reoperation for
LVOTO. Thus with enlargement of the VSD in an anteriosu-
perior direction and careful construction of the intraventric-
ular tunnel, these defects can be repaired without the need
for SV palliation.
Whether the patients in this series would have been better
served by an initial BVR, thus avoiding the need for com-
plex SV palliation takedown in addition to the challenges
of the BVR, is unknown. All of the patients in this series
would have undergone BVR at our institution, either primar-
ily (patients 2, 3, and 6–9) or after an interim systemic–PA
shunt (double-switch candidates, patients 1, 4, and 5). The
choice between a complex BVR and a relatively straightfor-
ward SV repair is a difficult one. However, the results of
a policy of BVR for patients such as patient 9 with LVOTO
and VSD have been published from our center with a 5-year
actuarial survival of 78%, which exceeds most published
studies for 5-year Fontan survival.25
In summary, carefully selected patients initially treated
with intent to perform an SV palliation can in some instances
be converted to 11/2- or 2-ventricle physiology with accept-
able outcomes. Although it can be still difficult to select be-
tween a complex, potentially high early mortality primary
BVR and an SV palliation with the potential for higher
late morbidity, a patient with adequately sized atrioventricu-
lar valves and adequate ventricular size and function would
be a good candidate for initial BVR. Although it is not pos-
sible to know what the outcome of a plan for BVR from the
outset would have been, these data would suggest that the
majority of these patients could have undergone BVR rather
than initial SV palliation, thus avoiding the need for complex
takedown of previous operations in addition to the challeng-
ing reconstruction.rdiovascular Surgery c Volume 141, Number 2 423
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